OCM and metabolic dysfunction-associated steatotic liver disease: Accumulating evidence indicate that dysregulation of OCM is associated with NAFLD, but rarely reported in VPA-induced liver disease (de Carvalho et al., 2013; Fernández-Ramos et al., 2022).